The FDA’s Gastroenterology-Urology Devices Panel voted unanimously that LINX’s Reflux Management System, a laparoscopically implanted device designed to treat gastroesophageal reflux disease, has a ...
(Reuters) -Johnson & Johnson said on Tuesday it will withdraw a device to treat acid reflux disease from certain markets outside the United States, citing commercial reasons. The company has decided ...
FDA has announced it has approved Torax Medical’s LINX Reflux Management System for treatment of gastroesophageal reflux disease, according to a news release. The LINX Reflux Management System is a ...
Mayo Clinic in Jacksonville, Fla., has announced it will be one of the first healthcare organizations in the United States to offer the LINX Reflux Management System to treat gastroesophageal reflux ...
Explore the entire Law.com network. Enjoy free access to one article from the Law.com network every 30 days*. *May exclude premium content. Subscribe to curated newsletters for the latest updates, ...
Johnson & Johnson (NYSE:JNJ) is one of the best conservative stocks to buy now. On September 23, the company announced plans to withdraw the LINX Reflux Management System in certain countries. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results